Академический Документы
Профессиональный Документы
Культура Документы
Study
In-depth knowledge for decision makers
High
The level of
social protection
Belgium
31%
31%
France
Medium
Germany
US
26%
26%
UK
Japan
Low
13%
27%
22%
Russia
China
5%
global topics
Social systems
Study 3
global topics
Transforming Social systems
This study is part of Project 2012, Roland Berger's GLOBAL TOPICS initiative
contents
introduction
Social systems as a global issue
p4
In sound health
Transforming social systems
p6
p 20
introduction
Study 5
In sound health
Study 7
f1
Belgium
138
249
260
794
2959
China
Russia
France
US
f2
France
Share of GDP: 31 %
Public: 92% Private: 8%
Russia
Share of GDP: 12,7%
Public: 100%1 Private: 0%
Belgium
Share of GDP: 31.1%
Public: 85% Private: 15%
US
Share of GDP: 26.4%
Public expenditures
China
Share of GDP: 5.2%
Private expenditures
Size of the circle represents the level of expenditure as a % of GDP
Source: OECD, National Statistics Bureau China, Ministry of Finance Russia 1) Private social expenditures not available
Study 9
f9
The soaring costs of healthcare can be attributed to a range of
factors, but four factors in particular lie at the core of the problem.
The first is the system's increasing reliance on and use of hightech diagnostics and prescription drugs. But despite this rising
use, non-communicable diseases, or NCDs (e.g. heart disease,
diabetes, Alzheimer's), are growing in prevalence as populations
f8
become more affluent and mortality rates drop. NCDs are the
second major cost factor. In 2001, global mortality rates from
NCDs stood at 59%; by 2010, this percentage had jumped to 67%.
On the one hand, widespread measures to prevent NCDs are
lacking; on the other hand, their growing prevalence means more
acute care and more long-term care, placing exponentially greater
demands on the system. A third cause behind rising healthcare
costs is an inadequate and inefficient supply of care itself.
Whiledeveloping nations face severe workforce shortages, most
developed nations simply have too many care providers.
f3
china
russia
US
+2.9%
+2.1%
+1.9%
2005
49.2
2005
40.9
2005
28.4
+1.0%
2005
28.8
2020
43.0
2005
46.9
sweden1 +1.7%
france
2020
52.1
2020
48.8
2020
30.1
2020
29.8
Healthcare
The growing impact of technology and prescription drugs
As the impact of technology and prescription drugs on the system
grows or, put another way, as the system's dependence
ontechnology and prescription drugs grows many countries are
seeking out more efficient tools and methods in their introduction
and use.
High tech is both a blessing and a curse in countries like the US
and France, where the average number of diagnostic and magnetic
resonance imaging (MRI) exams has increased sharply since
2000. Curbing unnecessary or redundant medical tests and
implementing monitoring systems are on the agendas of many
stakeholders. Belgium, which conducts more CT scans than any
other European country, is discussing a governmental proposal
tocurtail radiology expenses from the top down. Similarly, French
political leaders are looking into ways to reduce the costs of
testing.
But high costs do not necessarily have to accompany
technological advancements. Implemented well and innovatively,
technology can go a long way toward reducing healthcare
costs.Developing countries like China and Russia, where
technology useis still maturing, are investigating sustainable
reimbursementmodels in the modernization of services. In
France, several e-health initiatives have been launched which are
improving not only cost figures but also patient care and the
healthcare structures that support it. High administrative costs in
the healthcare sector are also being tackled by mobile payment
platforms like the RAZCODE system in the US, which uses 2D
barcodes to share health information and initiate payments.
Study 11
f4
Pensioner
Worker
1950
France
US
Russia
China
Source: EIU
2010
f5
Birth rates
Change in birth rate, Births per 1,000
CHIna
RUSsia
US
FRAnce
Belgium
1960 2010
people, 2010
-24
-14
-10
-5
-5
13
11
14
13
12
Life expectancy
Change in life expectancy Life expectancy at
at birth, 1960 2010
CHIna
FRAnce
Belgium
US
RUSsia
Sources: World Bank, UN
+30
+11
+10
+8
+2
69
81
80
78
73
Study 13
In almost every illness and disease area, prescription drug use and
its costs are rising. The US saw a USD 7 billion rise between 2009
and 2010 alone. In 2000, total pharmaceutical expenditure in
France was EUR 400 per capita. By 2008, that figure had jumped
to about EUR 550. One initiative to reduce this cost burden is the
recent development in France of paperless prescriptions, currently
active in 900 pharmacies but set to expand to 23,000 pharmacies
by 2013. Paperless prescriptions can save up to two hours of
pharmacy labor as well as significantly reduce the burden
oninsurance, which spends EUR 4 million a year on the collection
of prescriptions alone. Companies such as IBM and DocMorris
arealso innovating the way drugs are supplied and how the data
on their use and outcomes is collected. In addition to innovative
approaches such as this, many countries are encouraging the
prescription of generic drugs over name brands, usually through
incentives offered to the doctors and providers themselves.
Curbing the rise of NCDs
The healthcare system is also under pressure from the growing
prevalence of NCDs. In France, for example, the number of NCD
patients grew annually by 6% between 2008 and 2010, and NCDs
account for 70% of the country's health expenditure. Though
politicians are looking for infrastructural ways to reduce or contain
the rising costs of NCDs, payors (the public insurance system and
complementary insurance providers) are also pursuing
preventative measures across the care spectrum. These include
primary measures (to avoid disease development entirely),
secondary (early diagnosis and reduced morbidity) and tertiary
(restoring function and minimizing complications). The Vigisant
pilot program was recently launched in the northern region of
France to detect hypertensive employees of participating
companies. These employees were then monitored at home via
telemedicine technologies.
Disease management programs like these have great potential to
reduce the severity of NCDs as well as their associated costs. In
the US, the Metabolic Syndrome Program is saving about EUR 716
per patient through daily monitoring, personal coaching and
coordination efforts between relevant care providers. Similar
programs in Germany and the Netherlands are also proving that
significant cost savings can be achieved through disease
management. In China, insurance coverage is being expanded as
away to bring the costs of NCDs under control. A cooperative
medical system (the NCMS) was established in 2003 as a largely
government-financed insurance scheme for rural populations. It
began with 90% coverage of 20 serious diseases, but that number
was brought to 25 in 2010.
f6
+46%
Russia
France +26%
sweden +20%
1
china
US
+14%
+13%
2005
5%
2010
8%
2005
11%
2010
14%
2005
9%
2005
4%
2005
15%
2010
11%
2010
5%
2010
17%
Study 15
Very clean
10
Sweden1 9.3
US 7.1
France 7.0
7
f7
Corruption is a major
challenge for social
systems in all
countries, especially
in emerging countries
such as China and
Russia
China 3.6
Russia 2.4
Highly corrupt
f8
67%
2010
Global death rates from non-communicable diseases, 2001 and 2010 (%)
59%
2001
Source: CFR
f9
Cardiovascular disease
Cancer
Diabetes
Weight problems & obesity
Other chronic
All other
33%
20%
11%
10%
9%
17%
0%
Total costs
Source: CDC
100%
74%
26%
Study 17
Pensions
Extending employment
The changed workforce is another epicenter of the pension issue,
and many countries, both developed and developing, are
findinginnovative solutions. Two categories of measures have
emerged. The first are those that extend the span of working life
through incentives for both the employee and the employer.
China,for example, is moving toward making its retirement plans
fully portable, and many Western European countries have
recently extended the required number of working years. Germany
has reduced mandatory pension contributions for companies that
hire workers over the age of 50. And France is considering a payas-you-go system similar to the one adopted in Sweden, where the
pension received is based on one's personal contribution and life
expectancy. Sweden's move in this direction was the first truly
structural change to the retirement system, and similar profound
changes are likely to be seen elsewhere.
f10
Source: WHO
Japan
Italy
Spain
80
Greece
Poland
76
China
Brazil
68
Germany
France
Belgium
Switzerland
Norway
US
Contain/reduce costs
Russia
India
64
Canada
Turkey
72
Iraq
UK
Sweden
Increase life
expectancy
60
56
52
South Africa
48
0
500
1,000
1,500
4,000
4,500
5,000
7,500
8,000
F11
europe is an example of a
worldwide trend the share of
employed citizens over 55 years
old is increasing as countries
react to demographic change
employment rates by age group, 2000 2010 (%)
Source: eurostat
Study 19
+3%
+33%
+24%
+12%
+30%
+22%
+79%
+29%
Sweden
+102%
2000:
78.6
46.0
4.9
2010:
80.7
61.0
6.3
+78%
+63%
finland
UK
2000:
63.2
36.1
5.2
2010:
70.8
44.0
8.5
+127%
2000:
58.5
22.8
2.3
2010:
72.5%
40.8
4.1
+53%
netherlands
2000:
54.1
18.5
2.6
2010:
70.1
37.3
5.9
+26%
+18%
+71%
+12%
Hungary
+20%
2000:
33.7
7.6
1.7
2010:
51.7
13.0
1.9
+75%
2000 2010
+45%
+25%
Spain
2000:
46.2
26.7
1.6
2010:
54.4
32.0
2.0
55 59 age group
france
2000:
48.1
10.2
1.1
2010:
60.6
17.9
1.6
60 64 age group
65+ age group
Study 21
f12
Relevant recommendation
1. Close
coverage gaps
Russia
China
US
France
Belgium
Source: Roland Berger
2. Minimize
fraud and
corruption
3. Improve
quality
of healthcare
4. Reduce
NCD burden
5. Increase
6. Cut
worker-pensioner healthcare
ratio
costs
1.
Close
coverage gaps
2.
Minimize fraud
and corruption
Study 23
3.
Improve quality
of healthcare
4.
Reduce
NCD burden
5.
6.
Cut healthcare
costs
Study 25
GLOBAL OUTLOOK:
TAKING THE LONG VIEW
The government's role in financing social systems is a sensitive
issue, especially in an election year like 2012. Leaders are largely
staying neutral in this arena despite the major impact it can have
on national progress. But the urgency of this challenge reaches far
beyond election years and results. Steps must be taken. Luckily,
leaders from developed and developing countries alike can extract
three basic tenets in the changing social systems landscape:
1. Social systems improvements can best be made through
national guidelines that are implemented, managed and controlled
at the regional and local levels
2. Adjusting the retirement age is unavoidable. The world is ageing,
and increasing the retirement age is an "easy" step towards
finding a new equilibrium
3. NCDs are a global issue, and must be seen that way. Healthcare
players must cooperate locally and across borders to reach
the right groups with the right measures
In addition to these three primary steps, developing countries
withlow debt levels, like Russia and China, must invest directly in
healthcare and pensions by increasing social spending. On the
flipside, developed countries like Belgium, France and the US,
which face high levels of debt, must reduce and control social
spending through cost-efficiency measures if they are to maintain
the current quality of their systems and avoid continued
privatization.
Certainly businesses will experience both positive and negative
effects as social systems are fundamentally reexamined,
challenged and innovated. Though insurance companies and asset
managers will be strained in places like the US, they will also
findnew business opportunities in developing countries like
Russia and China as will healthcare and technology providers.
But in developed countries, such providers will also be asked to
adjust their business models to the changed and changing
landscape. Pharmaceutical companies, facing pressure in more
mature markets where spending cuts will occur, will be able to
turnto developing countries for new business, but in China may
encounter obstacles as the drug distribution channels are
broughtabove board.
f3
Vanessa Mrosek
Senior Consultant, Frankfurt
Phone: +49 30 399 27 36 06
vanessa.mrosek@rolandberger.com
special thanks
Country assessments: Huanqiong Wang, Chen Wen, Alain Chagnaud,
CharlotteFeryn, Mathias Garny, Ekaterina Kozlova, Yury Shakhmatov,
ShivamSaxena, Christopher Hoyes, Barbara-Maria Loth
Project management GLOBAL TOPICS: Torsten Oltmanns, Adele Huber
Publication management: Katherine Nlling, Marlena Koppendorfer
Charles-Edouard Boue
Member of the Executive Committee,
President Roland Berger Asia
Phone: +33 1 53670 965
charles-edouard.bouee@rolandberger.com
Study 27
CONTRIBUTING EXPERTS
Yan Kang
Partner, Beijing
Maria Mikhaylenko
Principal, Moscow
Dominique Gautier
Partner, Paris
Jrgen Reers
Partner, Detroit
Bruno Colmant
Partner, Brussels
Thomas Wendt
Principal, Detroit
Dmitri Zaitsev
Partner, Moscow
Phone: +7 495 287 92 46
dmitri.zaitsev@rolandberger.com
Sources
Center for Disease Control (CDC)
US: Share of chronic diseases costs in total healthcare costs, 2010
Council of Foreign Relations (CFR)
Global action on non-communicable diseases, 2011
Department for International Development (DFID)
Strategies to tackle corruption in the healthcare sector
of emerging markets, 2010
Economist Intelligence Unit (EIU)
GINI Index, 2010 2020p
Healthcare spending as % of GDP, 2010
Public debt as % of GDP, 2011
Never too early: Tackling chronic disease to extend
healthy life years, 2012
Eurostat
Active ageing and solidarity between generations a statistical
portrait of the European Union, 2012
http://epp.eurostat.ec.europa.eu/cache/ITY_PUBLIC/3-13012012BP/EN/3-13012012-BP-EN.PDF
IMF
World economic outlook database, GDP in USD
GDP in USD, 2010
National Audit Office
International benchmark of fraud and error in
social security systems, 2006
National Statistics Bureau China
Public social spending as % of GDP, 1980 2012
Public and mandatory private spending as % of GDP, 1980 2007
Ministry of Finance Russia
Public social spending as % of GDP, 1980 2012
Public and private social spending as % of GDP, 1980 2007
OECD
Diagnostic exams, 2000 2010
Public social spending as % of GDP, 1980 2012
Public and mandatory private social spending in
% of GDP, 1980 2007
Retirement age per country, 2005
Total social expenditure in % of GDP (Delta 1980 2007)
ONS
Labor Force Survey, 2010
Roland Berger
Roland Berger Country Assessment, 2011
Transparency International
Corruption Perceptions Index, 2011,
http://cpi.transparency.org/cpi2011/
United Nations Statistics
Workforce/Pensioner Ratio, 1950 2010
United Nations, Department of Economic and Social Affairs,
Population Division
World Population Prospects: The 2010 Revision
Crude birth rate 1950 2010 (births per 1,000 people)
World Health Organization (WHO)
Life expectancy at birth, 2010
Life expectancy at birth compared to per capita health spending,
2009, (current USD, years)
Shortage of healthcare workers, 2007
Overview: Initiatives for prevention/promotion of
physical activity, 2012
World Bank
Fertility rates (delta 1960 2010)
Life expectancy at birth, 1960 2010
Social expenditures in current USD per capita, 2007
Population and demographics (delta 1960 2010)
Study 29
GLOBAL TOPICS
Project Description
2012 is a year of dramatic economic and social challenges and
one of potential political change, with transitions of power taking
place in 60 countries affecting 50 percent of the world's GDP. With
our initiative GLOBAL TOPICS, we assess the most pressing issues
and outline possible solutions to leaders. Leveraging the global
footprint of our firm, we focus on how debt, welfare issues, energy
supply and changes in demographics affect perspectives for
theworld. We also explore how Africa as an entire continent turns
these challenges into opportunities.
Project 2012
Project Description
Initiated by Roland Berger, Project 2012 is a collaborative venture
designed to advise business and political decision-makers. Together
with dedicated partners from universities and think tanks around
theglobe, such as the Yale World Fellows Program and HEC Paris,
Roland Berger will use the results of Project 2012 to provide a set of
strategic suggestions.
July 2012
Study 31